GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Praxair, Inc. (PX) [hlAlert]

Rating:
Equal Weight
PX
up 53.04 %

Praxair, Inc. (PX) rated Equal Weight with price target $115 by Barclays Capital

Posted on: Friday,  Jan 27, 2012  12:25 PM ET by Barclays Capital

Barclays Capital rated Equal Weight Praxair, Inc. (NYSE: PX) on 01/27/2012. Previously Barclays Capital rated Overweight Praxair, Inc. (NYSE: PX) on
04/03/2009., when the stock price was $68.73. Since then, Praxair, Inc. has gained 53.05% as of 01/22/2016's recent price of $105.19.
If you would have followed the previous Barclays Capital's recommendation on PX, you would have gained 53.04% of your investment in 2485 days.

Praxair, Inc. (Praxair) is an industrial gas supplier in North and South America. Praxair's primary products for its industrial gases business are atmospheric gases (oxygen, nitrogen, argon, rare gases) and process gases (carbon dioxide, helium, hydrogen, electronic gases, specialty gases, acetylene). The Company also designs, engineers, and builds equipment that produces industrial gases for internal use and external sale. Its surface technologies segment, operated through Praxair Surface Technologies, Inc., supplies wear-resistant and high-temperature corrosion-resistant metallic and ceramic coatings and powders. Praxair serves approximately 25 industries, such as healthcare and petroleum refining; computer-chip manufacturing and beverage carbonation; fiber-optics and steel making, and aerospace, chemicals and water treatment. In July 2009, Praxair's subsidiary, Praxair Surface Technologies, Inc., acquired Sermatech International Holdings Corp. from Arsenal Capital Partners.

Barclays Capital has assembled a world-class, award-winning team of analysts covering, credit, commodities, economics, emerging markets, equities, fixed income, foreign exchange and market strategy. We provide in-depth analysis of companies and macro coverage across asset classes, markets and the world’s economies. We have a highly quantitative approach and our research is underpinned by sophisticated analytics. Combined, these provide clients with the tools and insights necessary for successful risk management and financing. Our research teams are based in many of the world’s major financial centres providing our clients with a globally integrated perspective across products and geographies.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
1/27/2012 12:25 PM Buy
None
105.49 115.00
as of 12/31/2012
1 Week down  -0.26 %
1 Month up  2.08 %
3 Months up  5.36 %
1 YTD up  2.38 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
8/31/2011 12:25 PM Buy
None
98.57 105.00
4/3/2009 10:25 AM Buy
None
68.73 76.00

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy